| Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company“) (CSE: DOCT) (Frankfurt: 7FM3), is pleased to state that further to its news release dated January 14, 2021, announcing its letter of intent with Kayan Health Limited (“Kayan Health“), Kayan Health ... |